πŸ‡ΊπŸ‡Έ FDA
Patent

US 11246930

Reoviruses having modified sequences

granted A61KA61K35/13A61K35/765

Quick answer

US patent 11246930 (Reoviruses having modified sequences) held by ONCOLYTICS BIOTECH INC. expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ONCOLYTICS BIOTECH INC.
Grant date
Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K35/13, A61K35/765, A61K45/06, A61P